Literature DB >> 8405327

Epidemiological and clinical study of sickle cell disease in France, French Guiana and Algeria.

M de Montalembert1, M Guilloud-Bataille, J Feingold, R Girot.   

Abstract

The main clinical and haematological features of sickle cell patients were compared in 618 French, 50 Guianese and 87 Algerian patients. In homozygous sickle cell patients, the proportion of icteric subjects rises with age in all centres; the prevalence of splenomegaly reaches a peak in children from 1 to 5 years and then decreases; jaundice and splenomegaly are more often noted in Algerian and Guianese than French patients. The prevalence of painful crisis is comparable in the 3 centres. In 465 French SS children, having a mean age of 7.3 +/- 5.9 years, the prevalence of a past history of meningitis is 7.3%, of septicaemia 4.1% of osteomyelitis 8.8%. These percentages do not differ significantly between countries. Prevalence of a past history of cerebrovascular accident is 3.2% in French SS patients; 1.2% in SC, 3.8% in S beta thalassaemia. A past history of acute splenic sequestration was noted significantly more often in SS (11.75%) and S beta thalassaemia (14.3%) than SC (3.6%) in French children (p < 0.05). Proportions of subjects transfused at least once do not differ between countries; SS children are more transfused (64%) than SC (15.6%) and S beta thalassaemic (66%) (p < 10-4). Haemoglobin and reticulocyte counts do not differ significantly between countries. In conclusion, no major differences were detected between French, Guianese and Algerian homozygous sickle cell patients: this may be due to the fact that France is in itself a mosaïc of ethnic origins.

Entities:  

Mesh:

Year:  1993        PMID: 8405327     DOI: 10.1111/j.1600-0609.1993.tb00613.x

Source DB:  PubMed          Journal:  Eur J Haematol        ISSN: 0902-4441            Impact factor:   2.997


  7 in total

1.  Blood transfusion rate in Congolese patients with sickle cell anemia.

Authors:  L M Tshilolo; R K Mukendi; S O Wembonyama
Journal:  Indian J Pediatr       Date:  2007-08       Impact factor: 1.967

Review 2.  Sickle cell disease: new opportunities and challenges in Africa.

Authors:  J Makani; S F Ofori-Acquah; O Nnodu; A Wonkam; K Ohene-Frempong
Journal:  ScientificWorldJournal       Date:  2013-09-19

3.  [Sickle cell disease in stationary phase in 6-59 months children in Lubumbashi: epidemiology and clinical features].

Authors:  Mick Ya Pongombo Shongo; Olivier Mukuku; Toni Kasole Lubala; Augustin Mulangu Mutombo; Gray Wakamb Kanteng; Winnie Sombodi Umumbu; Robert Mbuli Lukamba; Stanislas Okitotsho Wembonyama; Oscar Numbi Luboya
Journal:  Pan Afr Med J       Date:  2014-09-24

Review 4.  Neurologic complications of sickle cell disease in Africa: A systematic review and meta-analysis.

Authors:  Jean Jacques Noubiap; Michel K Mengnjo; Nicolas Nicastro; Joseph Kamtchum-Tatuene
Journal:  Neurology       Date:  2017-09-01       Impact factor: 9.910

5.  [Epidemiological, clinical and hematological profiles of homozygous sickle cell disease during the intercritical period among children in Ziguinchor, Senegal].

Authors:  Lamine Thiam; Assane Dramé; Isabelle Zokébé Coly; François Niokhor Diouf; Ndiogou Seck; Djibril Boiro; Aliou Abdoulaye Ndongo; Idrissa Basse; Babacar Niang; Indou Deme/Ly; Assane Sylla; Ibrahima Diagne; Ousmane Ndiaye
Journal:  Pan Afr Med J       Date:  2017-11-07

6.  Impact of voxelotor (GBT440) on unconjugated bilirubin and jaundice in sickle cell disease.

Authors:  Paul Telfer; Irene Agodoa; Kathleen M Fox; Laurie Burke; Timothy Mant; Marzena Jurek; Margaret Tonda; Josh Lehrer-Graiwer
Journal:  Hematol Rep       Date:  2018-05-22

7.  Plasma Folate Levels in Acutely Ill and Steady State Pediatric Sickle Cell Disease Patients in Ghana.

Authors:  George O Adjei; Abdul M Sulley; Bamenla Q Goka; Christabel Enweronu-Laryea; Seth K Amponsah; Michael Alifrangis; Jorgen A L Kurtzhals
Journal:  J Blood Med       Date:  2020-11-03
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.